Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience

Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study

(2016) Jan C. Holter et al.   PLoS One

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England

(2016) Albert Jan van Hoek et al.   PLoS One

Relation of Cardiac Complications in the Early Phase of Community-Acquired Pneumonia to Long-Term Mortality and Cardiovascular Events

(2015) Roberto Cangemi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Ten-Year Mortality after Community-acquired Pneumonia. A Prospective Cohort

(2015) Dean T. Eurich et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

(2015) Marie-Josée J. Mangen et al.   EUROPEAN RESPIRATORY JOURNAL

Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease

(2015) Vicente F. Corrales-Medina et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit

(2015) Rodrigo Cavallazzi et al.   RESPIRATORY MEDICINE

Risk factors for hospital admission in the 28 days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort study

(2015) Elizabeth R C Millett et al.   BMJ Open

A population-based study on the impact of hospitalization for pneumonia in different age groups

(2014) Vincenzo Baldo et al.   BMC INFECTIOUS DISEASES

Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia

(2014) Jordi Adamuz et al.   JOURNAL OF INFECTION

Etiology and outcome of severe community acquired pneumonia in immunocompetent adults

(2013) Ali Khawaja et al.   BMC INFECTIOUS DISEASES

Epidemiology and Long-term Clinical and Biologic Risk Factors for Pneumonia in Community-Dwelling Older Americans

(2013) Sachin Yende et al.   CHEST

U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination

(2013) Marie R. Griffin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

(2010) Angel Vila-Corcoles et al.   BMC INFECTIOUS DISEASES

Cause‐specific long‐term mortality rates in patients recovered from community‐acquired pneumonia as compared with the general Dutch population

(2010) A.H.W. Bruns et al.   CLINICAL MICROBIOLOGY AND INFECTION

Predicting mortality in the elderly with community-acquired pneumonia: should we design a new car or set a new 'speed limit'?

(2010) V. Brito et al.   THORAX

Clinical and economic burden of community-acquired pneumonia among adults in Europe

(2010) T Welte et al.   THORAX

Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis

(2008) Sachin Yende et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE